Clinical, laboratory, and therapeutic differences between immunoglobulin E-mediated and non-immunoglobulin E-mediated cow's milk protein allergy in children.

Hasan M Isa, Marwa J Abdulnabi, Nawra S Naser, Fatema N Lahmda, Noor M AlAnsari, Zahra H Isa, Afaf M Mohamed
Author Information
  1. Hasan M Isa: Department of Pediatrics, Salmaniya Medical Complex, Manama 26671, Bahrain.
  2. Marwa J Abdulnabi: Department of Pediatrics, Salmaniya Medical Complex, Manama 26671, Bahrain.
  3. Nawra S Naser: Department of Pediatrics, Salmaniya Medical Complex, Manama 26671, Bahrain.
  4. Fatema N Lahmda: Department of Pediatrics, Salmaniya Medical Complex, Manama 26671, Bahrain.
  5. Noor M AlAnsari: Department of Pediatrics, Salmaniya Medical Complex, Manama 26671, Bahrain.
  6. Zahra H Isa: Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  7. Afaf M Mohamed: Public Health Directorate, Ministry of Health, Manama 26671, Bahrain.

Abstract

BACKGROUND: Although breast milk is ideal for newborns, in some cases, it is replaced with cow's milk, which contains proteins that increase the risk of cow's milk protein allergy (CMPA).
AIM: To evaluate CMPA prevalence in Bahrain and compare clinical characteristics of children with immunoglobulin E (IgE)- and non-IgE-mediated CMPA.
METHODS: This retrospective cohort study examined children with CMPA diagnosed at the pediatric gastroenterology outpatient clinic of the Salmaniya Medical Complex, Bahrain, between 2014 and 2022, and assessed CMPA prevalence. Clinical presentations, laboratory findings, dietary modifications, and outcomes were compared between children with IgE-mediated and non-IgE-mediated CMPA. Categorical variables were compared using Fisher's exact test or Pearson's test, whereas continuous variables were compared using Student's -test or the Mann-Whitney test.
RESULTS: Of 8332 patients, 6022 (72.3%) adhered to their appointment. Of them, 618 (10.3%) were suggested of having CMPA and 595 (96.3%) were included; CMPA prevalence was 2%. Most patients were Bahraini (93.8%) and males (55.3%). Non-IgE-mediated type accounted for 77.3% cases and IgE-mediated type, 22.7%. IgE-mediated CMPA presented more in boys ( = 0.030), and later in life (5.1 months ± 4.5 months 4.2 months ± 4.2 months, = 0.016, 95%CI: 0.08-1.73), had more associated diseases ( < 0.001); and presented with more cutaneous ( = 0.024) and respiratory ( = 0.003) manifestations, severe symptoms [rash/dry skin ( = 0.031), facial swelling/angioedema ( = 0.003), failure to thrive ( = 0.013), apparent life-threatening event ( < 0.001)], and positive physical findings ( = 0.002) than non-IgE-mediated CMPA. Most patients were exclusively fed cow milk formula (50.3%). The amino acid-based formula (AAF) was most prescribed (60.5%) with no difference between the two types ( = 0.173). Although breastfeeding was recommended to 49.6%, only 8.2% were exclusively breastfed. IgE-mediated CMPA was associated with a longer follow-up duration than non-IgE-mediated CMPA (17.3 months ± 14.0 months 13.5 months ± 13.4 months, = 0.005, 95%CI: 1.1-6.3).
CONCLUSION: This study revealed a high CMPA prevalence with clinical differences between both types that can influence treatment. AAF was most prescribed, while breastfeeding with dietary modification is rarely applied.

Keywords

References

  1. Allergol Immunopathol (Madr). 2006 Mar-Apr;34(2):46-53 [PMID: 16606545]
  2. J Allergy Clin Immunol. 2018 Feb;141(2):601-607.e8 [PMID: 29153857]
  3. World Allergy Organ J. 2024 Sep 10;17(9):100947 [PMID: 39310372]
  4. Allergol Int. 2012 Mar;61(1):107-13 [PMID: 22377523]
  5. AJR Am J Roentgenol. 2011 Jun;196(6):W817-22 [PMID: 21606275]
  6. World Allergy Organ J. 2013 Aug 06;6(1):13 [PMID: 23919257]
  7. Children (Basel). 2015 Jul 21;2(3):317-29 [PMID: 27417366]
  8. J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):386-413 [PMID: 38374567]
  9. J Allergy Clin Immunol. 1999 Jun;103(6):1173-9 [PMID: 10359902]
  10. J Pediatr (Rio J). 2010 Jul-Aug;86(4):285-9 [PMID: 20508909]
  11. Int J Environ Res Public Health. 2013 Oct 25;10(11):5364-77 [PMID: 24284354]
  12. Med Princ Pract. 2017;26(3):229-234 [PMID: 28226324]
  13. Nutrients. 2023 Mar 14;15(6): [PMID: 36986127]
  14. Nutrients. 2021 Sep 28;13(10): [PMID: 34684427]
  15. Int J Mol Sci. 2023 Mar 06;24(5): [PMID: 36902457]
  16. Neuro Endocrinol Lett. 2023 Oct 23;44(7):465-474 [PMID: 37874558]
  17. J Pediatr Gastroenterol Nutr. 1992 Jan;14(1):108-12 [PMID: 1573499]
  18. Acta Biomed. 2020 Sep 15;91(11-S):e2020012 [PMID: 33004782]
  19. Malawi Med J. 2019 Sep;31(3):227-229 [PMID: 31839894]
  20. Nutrients. 2024 Sep 09;16(17): [PMID: 39275351]
  21. BMC Nutr. 2024 Jul 19;10(1):101 [PMID: 39030656]
  22. Rev Gastroenterol Mex. 2014 Jan-Mar;79(1):3-6 [PMID: 24656514]
  23. Nutrients. 2019 Jun 26;11(7): [PMID: 31248015]
  24. Front Pediatr. 2021 Oct 21;9:744104 [PMID: 34746058]
  25. J Korean Med Sci. 2011 Sep;26(9):1152-8 [PMID: 21935269]
  26. Methods. 2014 Mar 1;66(1):22-33 [PMID: 23954566]
  27. Arch Argent Pediatr. 2018 Jun 1;116(3):219-223 [PMID: 29756713]
  28. Sudan J Paediatr. 2011;11(2):21-4 [PMID: 27493315]
  29. Nutr Diabetes. 2017 May 15;7(5):e274 [PMID: 28504710]
  30. J Pediatr (Rio J). 2013 Nov-Dec;89(6):554-8 [PMID: 24035877]
  31. World J Clin Pediatr. 2022 Nov 9;11(6):437-454 [PMID: 36439902]
  32. Int Sch Res Notices. 2015 Dec 16;2015:639796 [PMID: 27347535]
  33. Rev Gastroenterol Mex. 2015 Jan-Mar;80(1):27-31 [PMID: 25724742]
  34. Pediatr Gastroenterol Hepatol Nutr. 2014 Jun;17(2):61-73 [PMID: 25061580]
  35. Pol Merkur Lekarski. 2003 Sep;15(87):226-30 [PMID: 14679845]
  36. Rev Gastroenterol Mex. 2015 Apr-Jun;80(2):130-4 [PMID: 26024572]
  37. Int J Mol Sci. 2022 May 12;23(10): [PMID: 35628229]
  38. World J Pediatr. 2021 Dec;17(6):576-589 [PMID: 34817828]
  39. Allergol Immunopathol (Madr). 2023 Mar 01;51(2):90-98 [PMID: 36916092]
  40. J Asthma Allergy. 2023 Jan 05;16:73-82 [PMID: 36636707]
  41. Asian Pac J Allergy Immunol. 2022 Mar;40(1):65-71 [PMID: 31310148]
  42. J Pediatr Gastroenterol Nutr. 2013 Sep;57(3):281-6 [PMID: 23974059]

Word Cloud

Created with Highcharts 10.0.00CMPA=months3%milkprevalencechildrennon-IgE-mediatedIgE-mediated±4cow'sallergyBahraincomparedtestpatients5formulaAlthoughcasesproteinclinicalimmunoglobulinEstudyClinicallaboratoryfindingsdietaryvariablesusing2%typepresented1295%CI:associated<001003exclusivelyAAFprescribedtypesbreastfeeding313differencesE-mediatedBACKGROUND:breastidealnewbornsreplacedcontainsproteinsincreaseriskAIM:evaluatecomparecharacteristicsIgE-METHODS:retrospectivecohortexamineddiagnosedpediatricgastroenterologyoutpatientclinicSalmaniyaMedicalComplex20142022assessedpresentationsmodificationsoutcomesCategoricalFisher'sexactPearson'swhereascontinuousStudent's-testMann-WhitneyRESULTS:8332602272adheredappointment61810suggested59596includedBahraini938%males55Non-IgE-mediatedaccounted77227%boys030laterlife01608-173diseasescutaneous024respiratorymanifestationsseveresymptoms[rash/dryskin031facialswelling/angioedemafailurethrive013apparentlife-threateningevent]positivephysical002fedcow50aminoacid-based605%differencetwo173recommended496%8breastfedlongerfollow-upduration17140051-6CONCLUSION:revealedhighcaninfluencetreatmentmodificationrarelyappliedtherapeuticnon-immunoglobulinBreastfeedingChildrenImmunoglobulinInfantMilk

Similar Articles

Cited By